Effect of Zinc on Barrett's Metaplasia
Status unconfirmed · Phase 1
Conditions studied: Barrett's Metaplasia
In brief
Using orally administered zinc to patients already diagnosed with the pre-cancerous condition, Barrett's Esophagus, this study is asking two questions: 1. can this zinc administration cause molecular-level changes in the Barrett's tissue? 2. are the changes measured indicative of chemopreventive action by zinc regarding cancer progression?
Key facts
- Study ID
- NCT01984580
- Run by
- Main Line Health
- People needed
- 120
- Starts
- 2011-04-01
- Expected to finish
- 2015-12-01
- Last updated by the study team
- 2013-11-14
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Lankenau Institute for Medical Research — Wynnewood, Pennsylvania, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.